London, United Kingdom

Jethro Herberg

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Imperial College Innovations Limited, University of California. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jethro Herberg: Innovator in Kawasaki Disease Identification

Introduction

Jethro Herberg is a notable inventor based in London, GB. He has made significant contributions to the field of medical diagnostics, particularly in identifying Kawasaki disease. His innovative approach has the potential to improve the accuracy of diagnoses in patients presenting with similar symptoms.

Latest Patents

Herberg holds a patent for a method of identifying a subject having Kawasaki disease. This method includes discriminating the subject from others with different conditions, such as other infectious and inflammatory diseases. The patent also provides a minimal gene signature used in the method, along with primers, probes, and gene chips essential for its application.

Career Highlights

Throughout his career, Jethro Herberg has worked with prestigious institutions, including the University of California and Imperial College Innovations Limited. His work has focused on advancing medical research and improving diagnostic techniques.

Collaborations

Herberg has collaborated with esteemed colleagues, including Michael Levin and Jane C. Burns. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Jethro Herberg's contributions to the identification of Kawasaki disease exemplify the impact of innovation in medicine. His work continues to pave the way for advancements in diagnostic methods, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…